Frontlight ResearchEarly access
Taking people in United StatesNo phase
A Study to Evaluate the SENSE Device's Ability to Detect TBI
Key facts
- Who runs it
- Sense Diagnostics, LLC
- Where
- Charleston, Cincinnati, Gainesville, Houston, Pittsburgh, and San Antonio, United StatesSee the 6 sites
- Trial code
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 11 Jul 2025
- Planned end
- 30 Jun 2026
- Type of study
- Observational, 3 groups
- Treatments tested
- SENSE device
- Record updated
- 25 November 2025
Who can take part
- Age
- 22 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- • Male or female adults age 22 and older; Patients with TBI who have a head CT scan obtained in the mobile stroke unit, emergency department, or hospital, ordered by a treating clinician OR control subjects with normal brain health; For patients with traumatic intracranial hemorrhage, blood is visible on ≥ 3 consecutive axial CT slices; Signed written informed consent by study subject or, if subject is unable, by subject's next of kin or legally authorized representative; Willingness and ability to comply with schedule for study procedures
Who cannot take part
- • Female patients who are pregnant or lactating; SENSE Device is unable to be placed within 6 hours of a standard of care head CT and within 24 hours of injury; Open skull fracture (closed skull fracture is not an exclusion); Metallic intracranial clip, coil, or device (such as metallic ICP monitor); Presence or history of any other condition or finding that, in the investigator's opinion, makes the patient unsuitable as a candidate for the SENSE Device monitoring or study participation or may confound the outcome of the study; Planned placement of an intraventricular catheter prior to study enrollment; Planned intracranial surgery prior to study enrollment; Current participation in a medical or surgical interventional clinical trial; Use of continuous EEG monitoring at the time of enrollment; Clinical uncertainty about the presence or absence of hemorrhage on the enrolling head CT; Control subjects with normal brain health will have no known history of seizure, stroke, brain tumor, TBI requiring emergency room evaluation, concussion within the previous 6 months, hydrocephalus, intracranial vascular malformation, other structural brain disease, or intracranial surgery. Benign headache disorders (e.g. migraine headache, tension headache), and mild concussion > 6 months prior to enrollment are not exclusions
Where in United States
- MUSCCharleston, United StatesContact: Paige HallTaking people
- University of CincinnatiCincinnati, United StatesContact: Jason McMullan, MDTaking people
- University of FloridaGainesville, United StatesContact: Hector Meza Comparan, MDTaking people
- UT HoustonHouston, United StatesContact: Arun KaneTaking people
- University of PittsburghPittsburgh, United StatesContact: Evan GuTaking people
- UTSASan Antonio, United StatesContact: Martha De La MoraTaking people
About the trial
What the trial wants to find out
The study population will consist of 3 mutually-exclusive sets of patients and subjects:
Read full original descriptionShow less
* TBI patients with intracranial bleeding * TBI patients without intracranial bleeding * Control subjects with normal brain health.
Research subjects ages 22 and older will be enrolled. All TBI patients must be monitored with the SENSE Device within 6 hours of a diagnostic head CT scan ordered by a treating clinician and within 24 hours of injury.
The 3 groups in the trial
- TBI patients with intracranial bleeding
50 patients with TBI with intracranial bleeding
Treatment: SENSE device
- TBI patients without intracranial bleeding
50 patients with TBI without intracranial bleeding
Treatment: SENSE device
- Control subjects with normal brain health
50 control subjects with normal brain health
Treatment: SENSE device
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Prospective, Non-randomized, Sequentially-enrolled, Multi-center, Phase II Study to Evaluate the SENSE Device's Ability to Detect Traumatic Brain Injury
- Record updated
- 25 November 2025